Siteman Cancer Center

Leading cancer care from prevention to survivorship with advanced research, individualized treatment, and dedicated care coordination support.

[Siteman Cancer Center @SitemanCenter]

We're honored that @Newsweek has recognized Siteman as the No. 1 cancer center in Missouri and Illinois — and among the best of the best nationally.

https://t.co/zMG0TdV02B

[ASTRO @ASTRO_org]

Congratulations to Jeff Michalski, MD, MBA, FASTRO (@jmmrad) on being named an Honorary Member of the American Association of Physicists in Medicine (AAPM). @aapmHQ

Dr. Michalski was awarded during #AAPMcomp2026 on July 20.

[WashU Medicine Radiation Oncology @WashUMedRadOnc]

Congratulations to @jmmrad! He will be awarded tonight at #AAPMcomp2026 with honorary membership in @aapmHQ for his support for the mission and goals of AAPM through leadership and advocacy! 🙌

[Siteman Cancer Center @SitemanCenter]

Read more: https://t.co/DMe3RTAVSP

[Siteman Cancer Center @SitemanCenter]

Congratulations to @washumedicine's Cynthia X. Ma, MD, PhD, on receiving a Susan G. Komen Leadership Grant. Ma, a medical oncologist at Siteman, aims to guide more personalized treatment for breast cancer by studying why certain cancers become resistant to hormone therapy.

[Siteman Cancer Center @SitemanCenter]

Congratulations to @washumedicine's Graham A. Colditz, MD, DrPH, and Shu (Joy) Jiang, PhD, on receiving the 2026 Chancellor's Award for Innovation and Entrepreneurship for their AI mammography technology that predicts personalized breast cancer risk. https://t.co/hE559YYDmK

[Siteman Cancer Center @SitemanCenter]

@WashUMedRadOnc @KaramLab @jmmrad @gdhugo @SMarkovina2 @AllisonLehman14 @UNCMedCenter @KUMedCenter @IowaMed @BCMAR_HISD Welcome!

[Siteman Cancer Center @SitemanCenter]

Congratulations to @washumedicine's Gregory J. Zipfel, MD, on being elected president of the Society of Neurological Surgeons. He is the fifth chair of the Taylor Family Department of Neurosurgery to lead the society, a legacy dating back to 1920. https://t.co/FSHqOnho2h

[Siteman Cancer Center @SitemanCenter]

Optical Biopsy. Less than three minutes. @washumedicine researchers at Siteman developed a new 3D optical imaging method combined with machine learning to detect early endometrial cancer with 94% sensitivity. https://t.co/QKTIuIzToV

[Siteman Cancer Center @SitemanCenter]

New from @washumedicine and Siteman: Younger generations are aging faster biologically, and that accelerated aging is linked to rising early-onset cancer rates. Led by Yin Cao, ScD, MPH. Learn more: https://t.co/156GKaO9Sc

[Siteman Cancer Center @SitemanCenter]

What if what you eat feeds a tumor? @washu’s Gary Patti, PhD, of Siteman Cancer Center, is tracking how cancer cells feed themselves — and one finding is already turning heads: fructose fuels tumor growth. https://t.co/PISSAZSA1v

[Siteman Cancer Center @SitemanCenter]

Congratulations to @washumedicine's Ravi Vij, MD, of Siteman on this well-deserved honor. He has written 300+ papers and led multiple innovative clinical trials in blood cancer. https://t.co/vLnUjvXvQf

[Siteman Cancer Center @SitemanCenter]

Smoking duration v. pack-years: After analyzing data from nearly 1M vets, @washumedicine's Brendan Heiden, MD, suggests duration metrics may better identify individuals at higher risk for lung cancer: https://t.co/GbL0Jw3wOo #ASCO26

[Siteman Cancer Center @SitemanCenter]

As #ASCO26 wraps up, take a look at the @washumedicine research presented by Siteman members, including breakthroughs in head and neck, endometrial cancers and more: https://t.co/r9hID4IVbe

[Siteman Cancer Center @SitemanCenter]

New from #ASCO26: @washumedicine’s Brendan Heiden, MD, suggests a paradigm shift in lung cancer screening: changing the metric from tobacco-pack years to tobacco smoking duration. Learn more: https://t.co/l7k0YkRJH5

[Siteman Cancer Center @SitemanCenter]

Food insecurity and financial stress can negatively impact the biology of breast cancer and the outcomes of patients, @washumedicine medical oncologist Emily Podany, MD, of Siteman Cancer Center, tells us.

Watch her discuss these findings, which she presented at #ASCO26.

[WashU Medicine Division of Hematology @WashUHematology]

From Bench-to-Beside! WashU Hematology is excited to bring this research from the Oh Lab (@mpndoc) all the way to a clinical trial offered at @SitemanCenter. #TranslationalResearch

[Siteman Cancer Center @SitemanCenter]

The KEYNOTE-689 trial of pembro in locally advanced H&N cancer has yielded practice-changing results. Looking ahead, data from the study could help trial leaders, including Douglas Adkins, MD, develop more strategies to enhance survivability. #ASCO26

[Siteman Cancer Center @SitemanCenter]

With ongoing support, the best minds in cancer research can meet the challenge for the greater good of patients, said @washumedicine surgeon Sidharth Puram, MD, PhD, FACS, co-director of the Head & Neck Tumor Center at Siteman Cancer Center. #ASCO26.

[ASCO @ASCO]

#ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27!

[Siteman Cancer Center @SitemanCenter]

There’s new hope for patients diagnosed with neuroendocrine tumors. @washumedicine medical oncologist Nikolaos A. Trikalinos, MD, MS, of Siteman Cancer Center, discusses the advances, which he presented at #ASCO26.